AH
Alexandria Hammond B of A Securities Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
89bio
ETNB
$1.32B
| $8.87 | $29 |
227%
upside
| Buy | 12 days ago |
|
2 |
2
Akero Therapeutics
AKRO
$3.58B
| $44.72 | $64 |
43%
upside
| Buy | 3 months ago |
|
3 |
3
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $1,150 |
101%
upside
| Outperform | 9 months ago |
|
4 |
4
Pfizer
PFE
$141B
| $24.88 | $25 |
0%
upside
| Underperform | 9 months ago |
|
5 |
5
Moderna
MRNA
$9.78B
| $25.14 | $40 |
59%
upside
| Underperform | 9 months ago |
|
6 |
6
Eli Lilly
LLY
$652B
| $727.21 | $1,000 |
38%
upside
| Outperform | 9 months ago |
|
7 |
7
Johnson & Johnson
JNJ
$430B
| $178.43 | $190 |
6%
upside
| Outperform | 9 months ago |
|
8 |
8
Gilead Sciences
GILD
$143B
| $115.05 | $110 |
4%
downside
| Outperform | 9 months ago |
|
9 |
9
AbbVie
ABBV
$375B
| $212.56 | $205 |
4%
downside
| Outperform | 9 months ago |
|
10 |
10
Madrigal Pharmaceuticals
MDGL
$9.65B
| $432.89 | $150 |
65%
downside
| Underperform | 1 year ago |
|